Our findings revealed a causal impact of CD4+ TEM cell markers on the risk of PTB and COVID-19, providing evidence identifying two markers (GBP2 and LAG3) as prospective targets for the prevention of PTB and COVID-19 infection (Figure 7). The gene discussed is LAG3; the disease is COVID-19.